This agonist decreased the proliferation of BC cells and DNA synthesis, although apoptosis in BC cells was not observed, and Ki-67-positive proliferative tumor cells and breast tumor weight were reduced in in vivo experiments [84]. The gene discussed is MKI67; the disease is breast cancer.